ARKK vs RXST
ARK Innovation ETF (ARKK) versus Rxsight Inc (RXST) — a side-by-side from cached financials, not a winner call.
ARK Innovation ETF (ARKK) common stock listed on US.
Rxsight Inc (RXST) is a medical devices company listed on NASDAQ.
ARKK does not have a complete income-statement cache yet.
Latest reported RXST revenue for 2026-06-30 was $64.6M. Net income was -$28.0M. RXST currently screens at market cap $198.3M.
ARKK currently screens at market cap $0. RXST currently screens at market cap $198.3M.
Not investment advice. Open the ARKK and RXST stock pages for the full models.
Not investment advice.